StatPearls, LLC

  • Cataract
  • Glaucoma
  • Macular Edema
  • Sarcoidosis

Ocular Sarcoidosis

Ocular sarcoidosis is a granulomatous inflammatory disorder that can involve the orbit, lacrimal system, ocular surface, uvea, retina, optic nerve, and adnexal tissues, with potential complications that include glaucoma, cataract, macular edema, retinal vascular disease, and irreversible vision loss. Although tissue biopsy remains the diagnostic standard, clinicians often need to integrate ocular findings with systemic evaluation, imaging, laboratory testing, and exclusion of infectious or malignant mimics. The practice gap is inconsistent recognition, diagnostic classification, complication monitoring, and treatment escalation in patients with suspected or confirmed ocular sarcoidosis. This educational activity addresses that gap by reviewing characteristic presentations, diagnostic criteria, differential diagnoses, corticosteroid and immunosuppressive treatment strategies, biologic therapy considerations, prognostic factors, and interprofessional coordination. Participants are expected to gain actionable skills that improve diagnostic accuracy, evidence-based treatment selection, complication prevention, and patient-centered outcomes.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 2 creditsAMA PRA Category 1 Credit™Up to 2 creditsNursingUp to 2 creditsPharmacyUp to 2 credits

MOC types

ABS — Accredited CMEUp to 2 pointsABPATH — Lifelong LearningUp to 2 pointsABTS — Accredited CMEUp to 2 pointsABIM — Medical KnowledgeUp to 2 pointsABS — Self-AssessmentUp to 2 pointsABTS — Self-AssessmentUp to 2 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 2 credits
  • MOC · Up to 2 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left